![Kenneth R. Chien](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth R. Chien
Directeur/Membre du Conseil chez
eTheRNA immunotherapies NV
Profil
Kenneth R.
Chien was the founder of Moderna, Inc. (2010), ModernaTX, Inc. (2011), and Celladon Corp.
(2000) where the title held was Director from 2009 to 2010.
Current jobs include Director at eTheRNA immunotherapies NV since 2022, Professor at Harvard University, Professor at Karolinska Institutet, and Member at Harvard Stem Cell Institute.
Former jobs include Scientific Director at The General Hospital Corp.
and Principal at the University of California San Diego.
Postes actifs de Kenneth R. Chien
| Sociétés | Poste | Début |
|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Harvard Stem Cell Institute
 Harvard Stem Cell Institute BiotechnologyHealth Technology Provides research regarding stem cells necessary for the understanding of human development and disease and trains next generation stem cell scientists | Corporate Officer/Principal | - |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Directeur/Membre du Conseil | 22/08/2022 |
Anciens postes connus de Kenneth R. Chien
| Sociétés | Poste | Fin |
|---|---|---|
| MODERNA, INC. | Fondateur | - |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Directeur Technique/Scientifique/R&D | - |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Fondateur | - |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Develops molecular therapies for cardiovascular diseases | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Develops molecular therapies for cardiovascular diseases | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Stem Cell Institute
Harvard Stem Cell Institute BiotechnologyHealth Technology Provides research regarding stem cells necessary for the understanding of human development and disease and trains next generation stem cell scientists | Health Technology |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
